Eline Borger Rognli is a psychologist who has worked many years in the clinic treating patients with substance abuse problems. She is a popular speaker on topics such as the use of motivational interviewing (MI) and the treatment of patients with substance abuse and mental disorders.
At SERAF she is researching the relationship between substance abuse and psychosis. Get better acquainted with our PhD student Eline Borger Rognli.
In a new study by researchers from the Norwegian Institute of Public Health, SERAF and Hedmark University College, the results show that more young people aged 0-17 years are using psychotropic drugs than ten years ago. This is the most comprehensive overview of trends in the use of psychotropic drugs among children and young people so far made in Norway.
In a recent paper published in Quality of Life Research changes in quality of life (QoL) was investigated 6 months inpatient following detoxification treatment.
As a child she wanted to be a carpenter. Maybe that is the reason she believes a good scientist should be willing to learn from others and build on the existing knowledge, in true carpenter spirit.
Get to know our PhD student Ingeborg Skjærvø in this month’s Phd profile.
In a recently published paper in Journal of Substance Use, SERAF researchers investigated overdose deaths involving benzodiazepines and opioids (strong analgesics) in Oslo.
Different patterns of use of cannabis, cocaine, methamphetamine, heroin, ecstasy (MDMA) and ketamine was uncovered using advanced statistical methods of temporal wastewater data
The second article published by the NorComt team focuses on the quality of life of incoming patients and attempts to uncover patterns among people who seem to be struggling in particular.
As SERAF’s Danish alibi, he is investigating the use of addictive drugs in both Norway and Denmark. He is passionate about uniting the Danish field on addiction research, but he would probably also enjoy himself as team doctor for the Danish national football team. Get to know Phd-candidate Christian Tjagvad.
In a recently published qualitative case study, Ayna Johansen and colleagues have explored one client’s recovery from borderline personality disorder, trauma, and problem gambling.
2015 has been a very exciting, informative and productive year at SERAF. Here is a summary of what we have been doing in the past year.
SERAF researcher Sudan Prasad Neupane has been awarded a major grant from the FRIPRO scheme (Independent projects) at the Research Council of Norway for a research project on the relationship between alcohol, depression and immunology.
In a article just published, Ashley Muller, a Phd-candidate at SERAF reflects on her experiences conducting a project with marginalized research participants within the substance use disorder treatment field, in a language that was nonnative to her.
The US Food and Drug Administration has approved an easy-to-use nasal spray that can reverse overdoses from heroin and prescription painkillers.
Marianne Riksheim Stavseth dreams of finding the answers to the great medical challenges through statistics, but is in the meantime trying to deal with "missing data" at SERAF.
In an article just published in BMC Public Health, researchers at SERAF have aimed to describe the relationship between depressive symptoms and alcohol use at different levels of SES in a population-based sample of adults in Norway.
Opioid maintenance treatment (OMT) is regarded as a crime control measure. Yet, some individuals are charged with violent criminal offenses while enrolled in OMT. In a qualitative study from SERAF the role of substance abuse and morality in violent crimes among imprisoned individuals in OMT is explored.
A longitudinal register-based cohort study combining the European version of Europ-ASI interviews and the Swedish inpatient register showed that cannabis use was a risk factor for primary psychosis.
Several coincidences led Marianne T. S. Holter to SERAF as a PhD candidate: With a background in psychology, experience from being a counselor at the Norwegian Quit-line for smoking, and with both an interest in and an expertise on smoking cessation, she was the perfect candidate for the project on eHealth interventions and smoking cessation at SERAF.
Researchers at SERAF have investigated the transition from amphetamine-induced psychosis to schizophrenia and mortality in a small prospective sample.
Advanced statistics combined with wastewater seems to be a powerful tool to investigate the pattern of use of illicit drugs all over Europe.
Doctoral student at SERAF, Ingvild Holdø wants to find out more about the use of prescription medication in children under the age of three, and develop knowledge about more accurate use of sleep medications.
Researchers from SERAF - The Norwegian Centre for Addiction Research and Buskerud University College have examined how professionally lead self-help affects addiction recovery.
31 August - 1 September the first Conference on Overdose Awareness was held in Bergen, Norway.
Objectives To present the prevalence and incidence of cardiovascular disease (CVD) in a national cohort of patients seeking treatment for drug use disorders (DUD).
Ashley Muller received one of three awards given to the best masters theses of 2014 on topics related to Oslo. Knowledge Oslo is a cooperation between the municipality and the city’s many knowledge institutions, and distributes yearly research awards to studies that have contributed to Oslo’s knowledge base.
